Sfoglia per AUTORE
DULL P
Collezione AOU Novara
Items : 3
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]. in Vaccine / Vaccine. 2017 May 31;35(24):3279. doi: 10.1016/j.vaccine.2017.04.081. Epub 2017 May 5.
2017
AOU Novara
AOU Novara
Odueyungbo A; Prymula R; Esposito S; Diez-Domingo J; Bona G; Heath PT; Finn A; Jawad S; Voysey M; Snape MD; Iro MA; Toneatto D; Dull P; Pollard AJ;
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial. in Vaccine / Vaccine. 2017 Jan 5;35(2):395-402. doi: 10.1016/j.vaccine.2016.11.009. Epub 2016 Nov 30.
2017
AOU Novara
AOU Novara
Odueyungbo A; Prymula R; Esposito S; Diez-Domingo J; Bona G; Heath PT; Finn A; Jawad S; Voysey M; Snape MD; Iro MA; Toneatto D; Dull P; Pollard AJ;
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age. in The Pediatric infectious disease journal / Pediatr Infect Dis J. 2016 Apr;35(4):e113-23. doi: 10.1097/INF.0000000000001056.
2016
AOU Novara
AOU Novara
Voysey M; Finn A; Bona G; Esposito S; Principi N; Snape MD; Diez-Domingo J; Sokal E; Kieninger D; Prymula R; Dull PM; Kohl I; Barone M; Wang H; Toneatto D; Pollard AJ;